Provided by Tiger Trade Technology Pte. Ltd.

NEURIZON THERAPEUTICS LTD

0.078
-0.007-8.24%
Volume:1.11M
Turnover:90.22K
Market Cap:61.17M
PE:-4.43
High:0.086
Open:0.085
Low:0.075
Close:0.085
52wk High:0.165
52wk Low:0.053
Shares:784.22M
Float Shares:351.37M
Volume Ratio:1.24
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.018
EPS(LYR):-0.018
ROE:-137.94%
ROA:-45.31%
PB:4.81
PE(LYR):-4.43

Loading ...

Company Profile

Company Name:
NEURIZON THERAPEUTICS LTD
Exchange:
ASX
Establishment Date:
2000
Employees:
4
Office Location:
385 Bourke Street,Suite 2, Level 11,Melbourne,Victoria,Australia
Zip Code:
3000
Fax:
- -
Introduction:
PharmAust Limited operates as a drug discovery and development company in Switzerland, Australia, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers in humans and animals. Its lead candidate is Monepantel, which are in Phase II clinical trials for the treatment of cancer. The company also provides highly specialized medicinal and synthetic chemistry services on a contract basis to clients to the drug discovery and pharmaceutical industries. PharmAust Limited is based in Bentley, Australia.